CSIMarket
 


Syros Pharmaceuticals Inc   (SYRS)
Other Ticker:  
 

Syros Pharmaceuticals Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Syros Pharmaceuticals Inc in the third quarter 2023?
Syros Pharmaceuticals Inc recorded a cumulative net loss of $-105 million during 12 months ending in the third quarter 2023, resulting in a negative return on equity (ROE) of -122.04%.

Within the Major Pharmaceutical Preparations industry 320 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2023 from 3566 to 3602.

What is ROE?



Return On Equity (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Change -71.9 % 136.11 % 70.15 % 49.89 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -105 -95 -93 -95 -114
Return On Equity (TTM) -122.04 % -87.04 % -94.55 % -107.97 % -147.58 %
SYRS's Total Ranking # 3602 # 3566 # 3167 # 3955 # 0
Equity (TTM) in Millions 36 73 107 128 129
Seq. Equity Change -50.43 % -31.39 % -16.43 % -1.11 % 316.43 %
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry # 321
Sector # 683
Overall # 3602

Return On Equity Statistics
High Average Low
-63.8 %
-92.06 %
-153.62 %
(Sep 30 2018)   (Jun 30 2022)





SYRS Annual Return On Equity (Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
Total Equity in Millions 128 85 91 79 79
Y / Y Equity Change 49.89 % -5.89 % 14.36 % 0.76 % 20.3 %
Net Income in Millions -95 -87 -84 -75 -62
Y / Y Net Income Change - - - - -
Return On Equity -74.1 % -101.57 % -92.81 % -95.27 % -79.25 %





More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
SYRS's' Return on Equity at Yahoo Finance
SYRS's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for SYRS's Competitors
Return On Equity for Syros Pharmaceuticals Inc 's Suppliers
Roe for SYRS's Customers




Companies with similar Return On Equity at Sep 30 2023, within Healthcare Sector ROE


Date modified: 2023-11-16T19:22:29+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com